PlaqueTec recruits first ten patients in BIOPATTERN trial

PlaqueTec, a company identifying endotype-specific biomarkers to advance precision medicine for coronary artery disease (CAD), today announced that it has received the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approval to continue its BIOPATTERN trial following recruitment of the first ten patients with CAD.

Beyfortus approved in China to protect infants from RSV; Illumina investor files class action suit

AstraZeneca and Sanofi’s Beyfortus won an approval in China to prevent RSV lower respiratory tract infection in newborns and infants during their first RSV season.

January 3, 2024

Opinion | With the End of Chevron, Health and Environmental Experts’ Hands Are Tied

Cerceo is an academic hospitalist and environmental health advocate. The irony of a jubilant Fourth of July parade I attended with my kids last week

July 9, 2024

Scripps Research scientists uncover plausible pathway for protocell formation

Roughly 4 billion years ago, Earth was developing conditions suitable for life. Origin-of-life scientists often wonder if the type of chemistry found on the early

February 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.